Table 2 Outcomes according to treatment modality and presence of enlarged supradiaphragmatic lymph nodes
Neoadjuvant treatment | P-value | Upfront surgery | P-value | |||
|---|---|---|---|---|---|---|
Enlarged SDLN N = 19 | No enlarged SDLN N = 9 | Enlarged SDLN N = 28 | No enlarged SDLN N = 15 | |||
Progression free survival (median, months) | 9.7 | 16.5 | 0.09 | 15.1 | 21.5 | 0.11 |
% Optimal debulking* (< 10 mm) | 73.6% (14/19) | 100% (9/9) | 0.79 | 85.7% (24/28) | 100% (15/15) | 0.81 |
% No macroscopic disease | 57%(11/19) | 89%(8/9) | 0.09 | 78%(22/28) | 93%(14/15) | 0.06 |